Ireland vs Switzerland: Cause of death, by non-communicable diseases, male
Ireland
81.8%
in 2021
Switzerland
80.6%
in 2021
Ireland rank
16th
Switzerland rank
19th
Cause of death, by non-communicable diseases, male over time
- Ireland
- Switzerland
How they compare
Ireland currently reports 81.8% against 80.6% in Switzerland, a difference of 1.2%.
The two have swapped places 1 time across 6 shared years of data; in 2000 it was Switzerland ahead.
Ireland ranks 16th and Switzerland ranks 19th of 185 countries.
Across the 3 decades both report, Ireland averaged higher in 1 and Switzerland in 2.
Head to head by decade
| Decade | Ireland | Switzerland | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 85.1% | 87.2% | 2.1% | Switzerland |
| 2010s | 89.3% | 89.3% | 0.0% | Switzerland |
| 2020s | 83.8% | 78.8% | 4.9% | Ireland |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, male, Ireland or Switzerland?
- Ireland, at 81.8% against 80.6% in Switzerland as of 2021.
- What is the difference in cause of death, by non-communicable diseases, male between Ireland and Switzerland?
- 1.2%, with Ireland ahead.
- How many years of comparable data are there for Ireland and Switzerland?
- 6 years are reported by both, from 2000 to 2021.
- How do Ireland and Switzerland rank globally for cause of death, by non-communicable diseases, male?
- Ireland ranks 16th and Switzerland ranks 19th of 185 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, male (% of total male deaths). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of male deaths ages due to non-communicable diseases divided by number of all male deaths ages, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.